[Outcomes of excisional goniotomy using the Kahook Dual Blade in refractory glaucoma]
- PMID: 40784792
- DOI: 10.3760/cma.j.cn112137-20241210-02793
[Outcomes of excisional goniotomy using the Kahook Dual Blade in refractory glaucoma]
Abstract
The current study aimed to explore the efficacy and safety of excisional goniotomy using the Kahook Dual Blade (KDB-GTE) in refractory glaucoma. A total of 20 eyes from 19 subjects with mild to late-stage refractory glaucoma who underwent standalone KDB goniotomyor combined phacoemulsification plusintraocular lens (IOL) implantation (partially combined withgoniosynechialysis) in Beijing Tongren Hospital from August 2021 to April 2023 were included. There were 9 males and 10 females, with a mean age of (57±17) years and a follow-up time of (19.8±6.4) months.The preoperative intraocular pressure (IOP) decreased from (29.4±11.8) mmHg (1 mmHg=0.133 kPa) to (15.7±2.6) mmHg (P<0.001). The types of preoperativeanti-glaucoma medications were reduced from 4 (3, 4) to 2 (1, 3) (P<0.001). At 12-month follow-up, 70% (14/20) achieved a IOP of≤18 mmHg after medication. No severe complications were reported. This study suggests that KDB-GTE is an effective and minimally invasive surgery for refractory glaucoma, demonstrating significant reductions in both IOP and medication burden, with a favorable safety profile.
本研究探讨了Kahook双刃刀(KDB)内路小梁网切除术(KDB-GTE)治疗中晚期难治性青光眼的效果及安全性。回顾性纳入2021年8月至2023年4日在北京同仁医院行单纯KDB-GTE或联合白内障超声乳化吸除人工晶体植入术(部分联合房角分离术)治疗中晚期难治性青光眼的患者19例(20眼),男9例,女10例,年龄(57±17)岁。随访(19.8±6.4)个月,眼压从术前的(29.4±11.8)mmHg(1 mmHg=0.133 kPa)降至(15.7±2.6)mmHg(P<0.001);抗青光眼药物种类从术前的4(3,4)种减少至2(1,3)种(P<0.001)。随访12个月,70%(14/20)可达到用药下眼压≤18 mmHg,未观察到严重并发症发生。本研究结果提示,KDB-GTE可降低眼压,减少抗青光眼药物使用,手术安全性较好,是中晚期难治性青光眼可选的手术方式之一。.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
